Hitoshi Masuda
Japanese Foundation for Cancer Research
27 Papers
167 Citations
Hitoshi Masuda is an academic researcher from Japanese Foundation for Cancer Research. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 10, co-authored 27 publications.
Chat about Author
Papers
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate
T. Kijima,Yasuhisa Fujii,Taisuke Suyama,Yuhei Okubo,Shinya Yamamoto,Hitoshi Masuda,Junji Yonese,Iwao Fukui +7 more
TL;DR: To investigate the rate of objective response and the skeletal‐related event (SRE)‐free survival after combined therapy with radiotherapy (RT) and zoledronate in patients with bone metastases from renal cell carcinoma (RCC).
53
Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution.
Shinya Yamamoto,Satoru Kawakami,Junji Yonese,Yasuhisa Fujii,Shinji Urakami,Shinichi Kitsukawa,Hitoshi Masuda,Yuichi Ishikawa,Takuyo Kozuka,Masahiko Oguchi,Atsushi Kohno,Iwao Fukui +11 more
TL;DR: In this article, the authors compared the long-term oncological outcome of patients with clinical T3 (cT3) prostate cancer (PCA) treated with either radical prostatectomy (RP) or external-beam radiation therapy (EBRT) and identified predictors of oncology outcomes.
32
Long-term Oncological Outcome and Risk Stratification in Men with High-risk Prostate Cancer Treated with Radical Prostatectomy
Shinya Yamamoto,Satoru Kawakami,Junji Yonese,Yasuhisa Fujii,Shinji Urakami,Hitoshi Masuda,Noboru Numao,Yuichi Ishikawa,Atsushi Kohno,Iwao Fukui +9 more
TL;DR: Radical prostatectomy for high-risk prostate cancer provides good long-term local cancer control and cancer-specific survival, and can be considered a valuable therapeutic option as the first treatment.
27
Clinical outcome of urachal cancer in Japanese patients.
Tatsuro Hayashi,Takeshi Yuasa,Sho Uehara,Yasushi Inoue,Shinya Yamamoto,Hitoshi Masuda,Yasuhisa Fujii,Iwao Fukui,Junji Yonese +8 more
TL;DR: Urachal cancer is usually locally advanced at presentation and it has a high risk of distant metastases, however, long-term survival following surgical treatment occurs in a significant fraction of patients.
26
Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma
TL;DR: Diffusion‐weighted magnetic resonance imaging is expected to improve the diagnostic accuracy, and this qualitative information might allow individualized treatment strategies for patients with urothelial carcinoma.
23